Timothy Brocopp, a director at MDWerks, Inc., has reported the acquisition of 148,401 shares of the company. This transaction, dated October 27, 2026, is significant as it reflects Brocopp's ongoing commitment to the beverage industry and his role within the company.
Background
MDWerks, Inc. operates in the beverage sector, classified under the SIC code 2080. The company is incorporated in Delaware and has been active in the market. Brocopp's recent filing is part of a series of transactions he has made, with the most recent prior filing on August 24, 2026.
What the Filing Says
The SEC filing indicates that Brocopp acquired the shares at a price of $0.0674 per share. Following this transaction, he now owns a total of 3,422,003 shares of MDWerks, which shows his substantial stake in the company. The filing notes, "Represents the grant of shares of common stock issued on a quarterly basis pursuant to the Employment Agreement entered into between Reporting Person and the Issuer on November 18, 2024." This grant was approved by the company's board of directors.
Impact
Brocopp's acquisition may affect various stakeholders, including investors and the company's management team. His increased ownership could signal confidence in MDWerks' future prospects, potentially influencing investor sentiment and market perception.
What's Next
The filing does not say what happens next.
Read Next
Principal Global Investors Acquires 5.6% Stake in NICE Ltd.
Principal Global Investors Updates Stake in Suja Life, Inc.
Principal Global Investors Increases Stake in Collegium Pharma
Principal Funds Reduces Stake in National Healthcare Properties
Principal Global Investors increases stake in Castle Biosciences
Principal Global Investors Discloses 2.8% Stake in Brookfield










